THOMAS JAMES DOYLE

Insider Reports History

Location
San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by THOMAS JAMES DOYLE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kura Oncology, Inc. SVP, Finance & Accounting Common Stock 145,167 $1,228,214 $8.46 27 Jan 2026 Direct
Kura Oncology, Inc. SVP, Finance & Accounting Common Stock 500 $5,194 $10.39 27 Jan 2026 spouse's 401(k)
Kura Oncology, Inc. SVP, Finance & Accounting Option to purchase common stock 42,500 02 Jan 2026 Direct

Insider Reports Filed by THOMAS JAMES DOYLE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KURA Kura Oncology, Inc. 27 Jan 2026 5 -$60,426 4 SVP, Finance & Accounting 27 Jan 2026, 21:35
KURA Kura Oncology, Inc. 02 Jan 2026 2 $0 4 SVP, Finance & Accounting 06 Jan 2026, 16:30
KURA Kura Oncology, Inc. 13 Nov 2025 2 -$50,732 4 SVP, Finance & Accounting 14 Nov 2025, 20:00
KURA Kura Oncology, Inc. 27 Sep 2025 2 -$40,607 4 SVP, Finance & Accounting 29 Sep 2025, 19:30
KURA Kura Oncology, Inc. 28 Jan 2025 4 -$38,958 4 SVP, Finance & Accounting 28 Jan 2025, 20:54
KURA Kura Oncology, Inc. 02 Jan 2025 3 $0 4 SVP, Finance & Accounting 06 Jan 2025, 16:09
KURA Kura Oncology, Inc. 29 Jan 2024 3 -$41,262 4 SVP, Finance & Accounting 31 Jan 2024, 17:30
KURA Kura Oncology, Inc. 02 Jan 2024 2 $0 4 SVP, Finance & Accounting 04 Jan 2024, 16:08
KURA Kura Oncology, Inc. 16 Feb 2023 2 $0 4 SVP, Finance & Accounting 21 Feb 2023, 16:15
KURA Kura Oncology, Inc. 27 Jan 2023 2 -$21,502 4 SVP, Finance & Accounting 31 Jan 2023, 16:14
KURA Kura Oncology, Inc. 07 Feb 2022 2 $0 4 SVP, Finance & Accounting 09 Feb 2022, 16:50
KURA Kura Oncology, Inc. 07 Feb 2022 0 $0 3 SVP, Finance & Accounting 09 Feb 2022, 16:48